EP Patent

EP3687508A1 — Delivery pharmaceutical compositions including permeation enhancers

Assigned to Aquestive Therapeutics Inc · Expires 2020-08-05 · 6y expired

What this patent protects

Pharmaceutical compositions having enhanced active component permeation properties are described.

USPTO Abstract

Pharmaceutical compositions having enhanced active component permeation properties are described.

Drugs covered by this patent

Patent Metadata

Patent number
EP3687508A1
Jurisdiction
EP
Classification
—
Expires
2020-08-05
Drug substance claim
No
Drug product claim
No
Assignee
Aquestive Therapeutics Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.